IARC Monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC1994;61:177–240.
2.
ParkinDMBrayFFerlayJPisaniP: Global cancer statistics, 2002. CA Cancer J Clin2005;55:74–108.
3.
ColemanMPEsteveJDamieckiPArslanARenardH: Trends in cancer incidence and mortality. International Agency for Research on Cancer Scientific Publications No.121.Lyon: IARC1993 pp. 193–224.
4.
LaurenP: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classifcation. Acta Pathol Microbiol Scand1965;64:31–49.
5.
JarviOLaurenP: On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer. Acta Pathol Microbiol Scand1951;29:26–44.
6.
GuilfordPHopkinsJHarrawayJMcLeodMMcLeodNHarawiraPTaiteHScoularRMillerAReeveAE: E-cadherin germline mutations in familial gastric cancer. Nature1998;392: 402–405.
7.
UemuraNOkamotoSYamamotoSMatsumuraNYamaguchiSYamakidoMTaniyamaKSasakiNSchlemperRJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med2001;345:784–789.
8.
SolciaEFioccaRLuinettiOVillaniLPadovanLCalistriDRanzaniGNChiaravalliACapellaC: Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol1996;20:S8–22.
9.
Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut2001;49:347–353.
10.
DevesaSSBlotWJFraumeniJFJr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer1998;83:2049–2053.
11.
CorreaPHaenszelWCuelloCTannenbaumSArcherM: A model for gastric cancer epidemiology. Lancet1975;2:58–60.
12.
ParkinDM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer2006;118:3030–3044.
13.
KraftCSuerbaumS: Mutation and recombination in Helicobacter pylori: Mechanisms and role in generating strain diversity. Int J Med Microbiol2005;295:299–305.
14.
Van DoornLJFigueiredoCMegraudFPenaSMidoloPQueirozDMCarneiroFVanderborghtBPegadoMDSannaRDe BoerWSchneebergerPMCorreaPNgEKAthertonJBlaserMJQuintWG: Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology1999;116:823–830.
15.
CensiniSLangeCXiangZCrabtreeJEGhiaraPBorodovskyMRappuoliRCovacciA: Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 1996;93: 14648–14653.
16.
MaedaSYoshidaHIkenoueTOguraKKanaiFKatoNShiratoriYOmataM: Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut1999;44:336–341.
17.
PeekRMJrCrabtreeJE: Helicobacter infection and gastric neoplasia. J Pathol2006;208:233–248.
18.
NaitoMYamazakiTTsutsumiRHigashiHOnoeKYamazakiSAzumaTHatakeyamaM: Infuence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology2006;130:1181–1190.
19.
CoverTLBlaserMJ: Purifcation and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem1992; 267:10570–10575.
20.
KustersJGvan VlietAHKuipersEJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev2006;19:449–490.
21.
AthertonJCCaoPPeekRMJrTummuruMKBlaserMJCoverTL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem1995;270:17771–17777.
22.
MiehlkeSKirschCAgha-AmiriKGuntherTLehnNMal-FertheinerPStolteMEhningerGBayerdorfferE: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer2000;87:322–327.
23.
FigueiredoCMacHadoJCPharoahPSerucaRSousaSCarvalhoRCapelinhaAFQuintWCaldasCvan DoornLJCarneiroFSobrinho-SimoesM: Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst2002;94:1680–1687.
24.
GerhardMLehnNNeumayerNBorenTRadRScheppWMiehlkeSClassenMPrinzC: Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA. 1999;96:12778–12783.
25.
MatthewsGMButlerRN: Cellular mucosal defense during Helicobacter pylori infection: A review of the role of glutathione and the oxidative pentose pathway. Helicobacter2005; 10:298–306.
26.
StarkG: Functional consequences of oxidative membrane damage. J Membr Biol2005;205:1–16.
27.
GonzalezCASalaNCapellaG: Genetic susceptibility and gastric cancer risk. Int J Cancer2002;100:249–260.
28.
HamajimaNNaitoMKondoTGotoY: Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci2006;97:1129–1138.
29.
El-OmarEMCarringtonMChowWHMcCollKEBreamJHYoungHAHerreraJLissowskaJYuanCCRothmanNLanyonGMartinMFraumeniJFJrRabkinCS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature2000;404:398–402.
30.
El-OmarEMRabkinCSGammonMDVaughanTLRischHASchoenbergJBStanfordJLMayneSTGoedertJBlotWJFraumeniJFJrChowWH: Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology2003;124:1193–1201.
31.
MacHadoJCFigueiredoCCanedoPPharoahPCarvalhoRNabaisSAlvesCastro CCamposMLVan DoornLJCaldasCSerucaRCarneiroFSobrinho-SimoesM: A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology2003;125:364–371.
32.
WuMSWuCYChenCJLinMTShunCTLinJT: Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer2003;104:617–623.
33.
LuWPanKZhangLLinDMiaoXYouW: Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis2005;26:631–636.
34.
CamaroMCMeraRCorreaPPeekRMJrFonthamETGoodmanKJPiazueloMBSicinschiLZabaletaJSchneiderBG: Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev2006;15:1674–87.
35.
SicinschiLALopez-CarrilloLCamargoMCCorreaPSierraRAHenryRRChenJZabaletaJPiazueloMBSchneiderBG: Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and −10 genes. Int J Cancer2006;118:649–657.
36.
LeeJYKimHYKimKHKimSMJangMKParkJYLeeJHKimJHYooJY: Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett. 2005;225:207–214.
37.
LeeWPTaiDILanKHLiAFHsuHCLinEJLinYPSheuMLLiCPChangFYChaoYYenSHLeeSD: The —251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res2005;11:6431–6441.
38.
TaguchiAOhmiyaNShiraiKMabuchiNItohAHirookaYNiwaYGotoH: Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev2005;14:2487–2493.
39.
OhyauchiMImataniAYonechiMAsanoNMiuraAIijimaKKoikeTSekineHOharaSShimosegawaT: The polymorphism interleukin 8 2251 A/T infuences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut2005;54:330–335.
40.
SavageSAHouLLissowskaJChowWHZatonskiWCha-NockSJYeagerM: Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev2006;15:589–591.
41.
KamangarFAbnetCCHutchinsonAANewschafferCJHelzlsouerKShugartYYPietinenPDawseySMAlbanesDVirtamoJTaylorPR: Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control2006;17:117–125.
42.
BaenaALeungJYSullivanADLandiresIVasquez-LunaNQuinones-BerrocalJFraserPAUkoGPDelgadoJCClavijoOPThimSMeshnickSRNyirendaTYunisEJGoldfeldAE: TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun2002;3:482–487.
43.
ZintzarasE: Association of methylenetetrahydrofolate reduc-tase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: A meta-analysis. J Hum Genet2006;51:618–624.
44.
LiuFPanKZhangXZhangYZhangLMaJDongCShenLLiJDengDLinDYouW: Genetic variants in cyclooxy-genase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology2006;130:1975–1984.
45.
BocciaSLa TorreGGianfagnaFMannocciARicciardiG: Glutathione S-transferase T1 status and gastric cancer risk: A meta-analysis of the literature. Mutagenesis2006;21:115–123.
46.
SaadatM: Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: A meta-analysis. Cancer Sci2006;97:505–509.
47.
CarvalhoFSerucaRDavidLAmorimASeixasMBennettEClausenHSobrinho-SimoesM: MUC1 gene polymorphism and gastric cancer — An epidemiological study. Glycoconj J1997;14:107–111.
48.
HaenszelWKuriharaM: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst1968;40:43–68.
49.
CamargoMCYepezMCCeronCGuerreroNBravoLECorreaPFonthamET: Age at acquisition of Helicobacter pylori infection: Comparison of two areas with contrasting risk of gastric cancer. Helicobacter2004;9 (3):262–270.
50.
GoodmanKJCorreaP: Transmission of Helicobacter pylori among siblings. Lancet2000;355:358–362.
51.
BravoLEMeraRReinaJCPradillaAAlzateAFonthamECorreaP: Impact of Helicobacter pylori infection on growth of children: A prospective cohort study. J Pediatr Gastroenterol Nutr2003;37:614–619.
52.
MeraRMCorreaPFonthamEEReinaJCPradillaAAlzateABravoLE: Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol2006;16:347–351.
NahonSLahmekPMassardJLesgourguesBde SerreMariaud NTraissacLBodiquelVAdottiFDelasN: Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: A reliable association? Helicobacter2003;8:573–577.
55.
SullivanPBThomasJEWightDGNealeGEasthamEJCorrahTLloyd-EvansNGreenwoodBM: Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child1990;65:189–191.
56.
FoxJGBeckPDanglerCAWharyMTWangTCShiHNNagler-AndersonC: Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med2000;6:536–542.
57.
WharyMTSundinaNBravoLECorreaPQuinonesFCaroFFoxJG: Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: Possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev2005;14:1464–1469.
58.
SummersRWElliottDEUrbanJFJrThompsonRAWeinstockJV: Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology2005;128:825–832.
59.
JoossensJVHillMJElliottPStamlerRLesaffreEDyerANicholsRKestelootH: Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol1996;25:494–504.
60.
TsuganeS: Salt, salted food intake, and risk of gastric cancer: Epidemiologic evidence. Cancer Sci2005;96:1–6.
61.
JakszynPGonzalezCA: Nitrosamine and related food intake and gastric and oesophageal cancer risk: A systematic review of the epidemiological evidence. World J Gastroenterol2006;12: 4296–4303.
62.
BlockG: Epidemiologic evidence regarding vitamin C and cancer. Am J Clin Nutr1991;54:1310S–1314S.
63.
JenabMRiboliEFerrariPSabateJSlimaniNNoratTFriesenMTjonnelandAOlsenAOvervadKBoutron-RuaultMCClavel-ChapelonFTouvierMBoeingHSchulzMLinseisenJNagelGTrichopoulouANaskaAOikonomouEKroghVPanicoSMasalaGSacerdoteCTuminoRPeetersPHNumansMEBueno-De-MesquitaHBBuchnerFLLundEPeraGSanchezCNSanchezMJArriolaLBarricarteAQuirosJRHallmansGStenlingRBerglundGBinghamSKhawKTKeyTAllenNCarneiroFMahlkeUDel GiudiceGPalliDKaaksRGonzalezCA: Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis. 2006;27:2250–2257.
64.
CorreaPFonthamETBravoJCBravoLERuizBZaramaGRealpeJLMalcomGTLiDJohnsonWDMeraR: Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapyJ Natl Cancer Inst2000;92:1881–1888.
65.
YouWCBrownLMZhangLLiJYJinMLChangYSMaJLPanKFLiuWDHuYCrystal-MansourSPeeDBlotWJFraumeniJFJrXuGWGailMH: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst2006;98:974–983.
66.
DorantEvan den BrandtPAGoldbohmRAHermusRJSturmansF: Garlic and its signifcance for the prevention of cancer in humans: A critical view. Br J Cancer1993;67:424–429.
67.
SetiawanVWYuGPLuQYLuMLYuSZMuLZhangJGKurtzRCCaiLHsiehCCZhangZF: Allium vegetables and stomach cancer risk in China. Asian Pac J Cancer Prev2005;6:387–395.
68.
van PoppelGVerhoevenDTVerhagenHGoldbohmRA: Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol1999;472:159–168.
69.
HaraMHanaokaTKobayashiMOtaniTAdachiHYMontaniANatsukawaSShauraKKoizumiYKasugaYMatsuzawaTIkekawaTSasakiSTsuganeS: Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer2003;46:138–147.
70.
HuangHYCaballeroBChangSAlbergAJSembaRDSchneyerCRWilsonRFChengTYVassyJProkopowiczGBarnesGJ2ndBassEB: The effcacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med2006;145:372–385.
71.
SasazukiSInoueMHanaokaTYamamotoSSobueTTsuganeS: Green tea consumption and subsequent risk of gastric cancer by subsite: The JPHC Study. Cancer Causes Control2004;15:483–491.
72.
IARC monographs on the evaluation of carcinogenic risk to humans: tobacco smoke and involuntary smoking. Lyon, France: International Agency for Research on Cancer;2002; vol 83.
73.
MirvishSS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett1995;93:17–48.
74.
OtsujiEKuriuYIchikawaDOkamotoKHagiwaraAYamagishiH: Characteristics of gastric carcinoma invading the muscularis propria. J Surg Oncol2005;92:104–108.
75.
JemalASiegelRWardEMurrayTXuJSmigalCThunMJ: Cancer Statistics, 2006. CA Cancer J Clin2006;56:106–30.